267 related articles for article (PubMed ID: 30158345)
1. Optical Coherence Tomography Predictors for Recurrent Restenosis After Paclitaxel-Coated Balloon Angioplasty for Drug-Eluting Stent Restenosis.
Miura K; Tada T; Habara S; Kuwayama A; Shimada T; Ohya M; Murai R; Amano H; Kubo S; Otsuru S; Tanaka H; Fuku Y; Goto T; Kadota K
Circ J; 2018 Oct; 82(11):2820-2828. PubMed ID: 30158345
[TBL] [Abstract][Full Text] [Related]
2. Association between tissue characteristics assessed with optical coherence tomography and mid-term results after percutaneous coronary intervention for in-stent restenosis lesions: a comparison between balloon angioplasty, paclitaxel-coated balloon dilatation, and drug-eluting stent implantation.
Tada T; Kadota K; Hosogi S; Miyake K; Ohya M; Amano H; Izawa Y; Kanazawa T; Kubo S; Ichinohe T; Hyoudou Y; Hayakawa Y; Sabbah MM; Otsuru S; Hasegawa D; Habara S; Tanaka H; Fuku Y; Katoh H; Goto T; Mitsudo K
Eur Heart J Cardiovasc Imaging; 2015 Oct; 16(10):1101-11. PubMed ID: 25762559
[TBL] [Abstract][Full Text] [Related]
3. Late Restenosis After Paclitaxel-Coated Balloon Angioplasty Occurs in Patients With Drug-Eluting Stent Restenosis.
Habara S; Kadota K; Shimada T; Ohya M; Amano H; Izawa Y; Kubo S; Hyodo Y; Otsuru S; Hasegawa D; Tada T; Tanaka H; Fuku Y; Goto T; Mitsudo K
J Am Coll Cardiol; 2015 Jul; 66(1):14-22. PubMed ID: 26139053
[TBL] [Abstract][Full Text] [Related]
4. A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis.
Habara S; Iwabuchi M; Inoue N; Nakamura S; Asano R; Nanto S; Hayashi Y; Shiode N; Saito S; Ikari Y; Kimura T; Hosokawa J; Nakamura M; Kotani J; Kozuma K; Mitsudo K
Am Heart J; 2013 Sep; 166(3):527-33. PubMed ID: 24016503
[TBL] [Abstract][Full Text] [Related]
5. Association between tissue characteristics evaluated with optical coherence tomography and mid-term results after paclitaxel-coated balloon dilatation for in-stent restenosis lesions: a comparison with plain old balloon angioplasty.
Tada T; Kadota K; Hosogi S; Miyake K; Amano H; Nakamura M; Izawa Y; Kubo S; Ichinohe T; Hyoudou Y; Eguchi H; Hayakawa Y; Otsuru S; Hasegawa D; Shigemoto Y; Habara S; Tanaka H; Fuku Y; Kato H; Goto T; Mitsudo K
Eur Heart J Cardiovasc Imaging; 2014 Mar; 15(3):307-15. PubMed ID: 24042176
[TBL] [Abstract][Full Text] [Related]
6. Five-Year Outcomes After Paclitaxel-Coated Balloon Angioplasty for Drug-Eluting Stent Restenosis.
Miura K; Kadota K; Habara S; Shimada T; Ohya M; Amano H; Kubo S; Hyodo Y; Otsuru S; Tada T; Tanaka H; Fuku Y; Goto T
Am J Cardiol; 2017 Feb; 119(3):365-371. PubMed ID: 27894569
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter).
Rittger H; Waliszewski M; Brachmann J; Hohenforst-Schmidt W; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Schlundt C; Zimmermann S; Lonke S; von Cranach M; Markovic S; Daniel WG; Achenbach S; Wöhrle J
JACC Cardiovasc Interv; 2015 Nov; 8(13):1695-700. PubMed ID: 26476609
[TBL] [Abstract][Full Text] [Related]
8. Biological effect on drug distribution and vascular healing via paclitaxel-coated balloon technology in drug eluting stent restenosis swine model.
Li Y; Tellez A; Rousselle SD; Dillon KN; Garza JA; Barry C; Granada JF
Catheter Cardiovasc Interv; 2016 Jul; 88(1):89-98. PubMed ID: 26613810
[TBL] [Abstract][Full Text] [Related]
9. Predictors of Recurrent In-Stent Restenosis After Paclitaxel-Coated Balloon Angioplasty.
Koiwaya H; Watanabe N; Kuriyama N; Nishino S; Ogata K; Kimura T; Nakama T; Matsuura H; Furugen M; Shibata Y
Circ J; 2017 Aug; 81(9):1286-1292. PubMed ID: 28450676
[TBL] [Abstract][Full Text] [Related]
10. A prospective, multicenter, randomized trial of paclitaxel-coated balloon versus paclitaxel-eluting stent for the treatment of drug-eluting stent in-stent restenosis: results from the PEPCAD China ISR trial.
Xu B; Gao R; Wang J; Yang Y; Chen S; Liu B; Chen F; Li Z; Han Y; Fu G; Zhao Y; Ge J;
JACC Cardiovasc Interv; 2014 Feb; 7(2):204-211. PubMed ID: 24556098
[TBL] [Abstract][Full Text] [Related]
11. Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD-DES study.
Rittger H; Wöhrle J; Brachmann J; Hohenforst-Schmidt W; Schlundt C; Lonke S; von Cranach M; Markovic S; Achenbach S; Waliszewski M
Catheter Cardiovasc Interv; 2016 Oct; 88(4):529-534. PubMed ID: 26893095
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of optical coherence tomography of early and very late stent restenosis after drug-eluting stent implantation].
Liu ZJ; Shi B; Deng CC; Xu GX; Zhao RZ; Shen CY; Wang ZL; Liu HL
Zhonghua Yi Xue Za Zhi; 2017 Jun; 97(23):1778-1783. PubMed ID: 28647998
[No Abstract] [Full Text] [Related]
13. Vascular healing responses to paclitaxel coated balloons or everolimus eluting stents for the treatment of in-stent restenosis. Insights from optical coherence tomography.
McInerney A; Salazar C; Pérez-Vizcayno MJ; Jimenez-Quevedo P; Jiménez-Valero S; Brugaletta S; Romaguera R; Nombela-Franco L; Travieso-Gonzalez A; Jerónimo-Baza A; Tirado-Conte G; Fernández-Ortiz A; Escaned J; Alfonso F; Macaya C; Gonzalo N
Coron Artery Dis; 2022 Dec; 33(8):609-617. PubMed ID: 36238983
[TBL] [Abstract][Full Text] [Related]
14. Treatment of drug-eluting stents in-stent restenosis with paclitaxel-coated balloon angioplasty: Insights from the French "real-world" prospective GARO Registry.
Auffret V; Berland J; Barragan P; Waliszewski M; Bonello L; Delarche N; Furber A; Albert F; Carrié D; Eltchaninoff H; Pansieri M; Schneeberger M; Piot C; Marcollet P; Bedossa M
Int J Cardiol; 2016 Jan; 203():690-6. PubMed ID: 26583844
[TBL] [Abstract][Full Text] [Related]
15. Quantified frequency-domain optical coherence tomography analysis for the thin-high signals on restenotic tissue after paclitaxel-coated balloon angioplasty.
Kawashima H; Suzuki N; Katayama T; Takahashi S; Okabe R; Takamura S; Watanabe Y; Kyono H; Kozuma K
Heart Vessels; 2018 Jun; 33(6):583-589. PubMed ID: 29249006
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of neointimal morphology of lesions with or without in-stent restenosis: an optical coherence tomography study.
Lee SJ; Kim BK; Kim JS; Ko YG; Choi D; Jang Y; Hong MK
Clin Cardiol; 2011 Oct; 34(10):633-9. PubMed ID: 21928365
[TBL] [Abstract][Full Text] [Related]
17. Simple balloon dilation for drug-eluting in-stent restenosis: an optical coherent tomography analysis.
Arikawa R; Yamaguchi H; Takaoka J; Miyamura A; Atsuchi N; Ninomiya T; Atsuchi Y; Ohishi M; Terashima M; Kaneda H
Cardiovasc Revasc Med; 2015; 16(1):27-31. PubMed ID: 25578507
[TBL] [Abstract][Full Text] [Related]
18. Optical coherence tomography (OCT) in PCI for in-stent restenosis (ISR): rationale and design of the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) study.
Adriaenssens T; Dens J; Ughi G; Coosemans M; Onsea K; Dubois C; Sinnaeve P; Vrolix M; Desmet W
EuroIntervention; 2011 May; 7 Suppl K():K100-5. PubMed ID: 22027717
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel-coated balloon for the treatment of drug-eluting stent restenosis: subanalysis results from the Valentines I trial.
Loh JP; Stella PR; Sangiorgi G; Silber S; Stahnke S; von Strandmann RP; Torguson R; Waksman R
Cardiovasc Revasc Med; 2014 Jan; 15(1):23-8. PubMed ID: 24444473
[TBL] [Abstract][Full Text] [Related]
20. Everolimus-eluting stent implantation versus repeat paclitaxel-coated balloon angioplasty for recurrent in-stent restenosis lesion caused by paclitaxel-coated balloon failure.
Kubo S; Kadota K; Otsuru S; Hasegawa D; Habara S; Tada T; Tanaka H; Fuku Y; Katoh H; Goto T; Mitsudo K
EuroIntervention; 2015 Jan; 10(9):e1-8. PubMed ID: 25599699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
